Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.260
-0.140 (-3.18%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Coya Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 100 | 121 | 96 | 107 | 12 | - | |
| Market Cap Growth | 15.57% | 26.77% | -10.29% | 769.50% | - | - | |
| Enterprise Value | 53 | 93 | 65 | 96 | 24 | - | |
| Last Close Price | 4.26 | 5.80 | 5.73 | 7.41 | 4.74 | - | |
| PS Ratio | 12.58 | 15.27 | 26.94 | 17.78 | - | - | |
| PB Ratio | 2.07 | 2.82 | 2.42 | 2.99 | -1.46 | - | |
| P/TBV Ratio | 2.32 | 2.82 | 2.42 | 2.99 | - | - | |
| EV/Sales Ratio | 6.68 | 11.73 | 18.20 | 15.97 | - | - | |
| Debt / Equity Ratio | - | - | - | - | -1.54 | - | |
| Net Debt / Equity Ratio | -1.09 | -1.09 | -0.97 | -0.92 | -0.84 | -1.19 | |
| Net Debt / EBITDA Ratio | 2.31 | 2.31 | 2.23 | 4.45 | -0.76 | 0.89 | |
| Net Debt / FCF Ratio | 4.36 | 4.36 | 3.73 | 2.92 | -0.97 | 1.07 | |
| Asset Turnover | 0.17 | 0.17 | 0.08 | 0.24 | - | - | |
| Quick Ratio | 7.97 | 7.97 | 10.22 | 7.94 | 1.55 | 3.78 | |
| Current Ratio | 8.51 | 8.51 | 11.59 | 8.15 | 1.88 | 3.99 | |
| Return on Equity (ROE) | -51.39% | -51.39% | -39.57% | -58.64% | - | -81.90% | |
| Return on Assets (ROA) | -26.86% | -26.86% | -25.15% | -18.53% | -88.03% | -44.96% | |
| Return on Capital Employed (ROCE) | -46.00% | -46.00% | -42.50% | -20.30% | -203.10% | -133.70% | |
| Earnings Yield | -21.24% | -17.49% | -15.54% | -7.49% | -99.77% | - | |
| FCF Yield | -10.75% | -8.85% | -10.75% | -10.48% | -58.99% | - | |
| Buyback Yield / Dilution | -9.79% | -9.79% | -49.93% | -292.40% | -0.01% | -40.88% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.